Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16909909 | 1.00 | POLB (0.48) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL4968055 | 1.00 | POLB (0.48) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL12226905 | 1.00 | POLB (0.48) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL967161 | 0.93 | POLB (0.48) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL893248 | 0.91 | POLB (0.42) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL15172745 | 0.88 | POLB (0.46) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL23176525 | 0.87 | LMNA (0.52) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL3045980 | 0.87 | LMNA (0.52) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL187221 | 0.87 | LMNA (0.52) | POLBTDP1LMNAKDM4EPMP22 | |
| SCHEMBL14433686 | 0.87 | LMNA (0.52) | POLBTDP1LMNAKDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150203667-A1 | CROSSLINKED NATIVE AND WAXY STARCH RESIN COMPOSITIONS AND PROCESSES FOR THEIR MANUFACTURE | CORNELL UNIVERSITY (US) | 2015-07-23 | — | — | US | claimed |
| WO-2026100662-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20250348000-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250155813-A1 | PROTECTIVE FILM FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| CN-119856108-A | Liquid crystal aligning agent and liquid crystal display element | 日产化学株式会社 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025033304-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-02-13 | — | — | WO | disclosed |
| CN-119301526-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2025-01-10 | — | — | CN | disclosed |
| CN-112313571-B | Method for manufacturing zero-face anchor film and liquid crystal display element | 日产化学株式会社 | 2024-11-19 | — | — | CN | disclosed |
| CN-112292633-B | Method for manufacturing zero-face anchor film and liquid crystal display element | 日产化学株式会社 | 2024-11-19 | — | — | CN | disclosed |
| CN-118829938-A | Weak anchoring liquid crystal aligning agent and liquid crystal display element | 日产化学株式会社 | 2024-10-22 | — | — | CN | disclosed |
| WO-2009152068-A1 | ASYMMETRIC CYCLIC DIESTER COMPOUNDS | FERRO CORPORATION (US) | 2009-12-17 | — | — | WO | disclosed |
| US-20090312470-A1 | Asymmetric Cyclic Diester Compounds | FERRO CORPORATION (US) | 2009-12-17 | — | — | US | disclosed |
| US-7507450-B2 | Varnish for forming liquid crystal alignment layer and liquid crystal display element using the same | CHISSO CORPORATION (JP) | 2009-03-24 | — | — | US | disclosed |
| US-7373060-B2 | Optical waveguide using polymer composed of silsesquioxane derivative | CHISSO CORPORATION (JP) | 2008-05-13 | — | — | US | disclosed |
| US-20070190344-A1 | Verification of translation | JNC CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20060204192-A1 | Optical waveguide using polymer composed of silsesquioxane derivative | JNC CORPORATION (JP) | 2006-09-14 | — | — | US | disclosed |
| US-20060204680-A1 | Varnish for forming liquid crystal alignment layer and liquid crystal display element using the same | JNC CORPORATION (JP) | 2006-09-14 | — | — | US | disclosed |
| US-6949281-B1 | Varnish composition and liquid-crystal display element | CHISSO CORPORATION (JP) | 2005-09-27 | — | — | US | disclosed |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | CHISSO CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-0082402-A2 | Succinimide derivates and process for preparation thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312470-A1 | Asymmetric Cyclic Diester Compounds | DDT, PCNA, AADAC | POLB 582/4885TDP1 2109/4885LMNA 3399/4885 |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | C1S, H1-4, H1-0 | POLB 2390/4885TDP1 4164/4885LMNA 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.